Cite
HARVARD Citation
Lefebvre, T. et al. (n.d.). P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?. Journal of Crohn's and colitis. pp. S361-S362. [Online].